Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$7.2M
Market Cap • 25/04/20242005
(há 19 anos)
2007
(17 years ago)
NASDAQ
Listagem
Pasadena
Sede • California4
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
LIXTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.